Loading...
XTAE
BLWV-M
Oct 26, Last price  
322.60ILS
1D
0.00%
Jan 2017
-94.75%
IPO
-99.96%
Name

Pharmocann Global Ltd

Chart & performance

D1W1MN
XTAE:BLWV-M chart
P/E
—
P/S
—
EPS
Vol. 1Y
140.28%
Shs. 5Y
—
Rev. 5Y
19.63%
Div Yld LY
—
Div Yld TTM
—
Revenues
Net income
CFO

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Key people

Chief Financial Officer · since 2009
Avital Perelstein
Vice President - Finance · since 2019
Eyal Sandach
Chief Operating Officer, General Manager · since 2013
Dan Eidelman
Vice President-Strategy at Pharmocann Ltd. · since 2019
Roi Hovesh
Vice President-Operations at Pharmocann Ltd. · since 2019
Nitzan Ravon Levy
Head of Training and Customer Services at Pharmocann Ltd. · since 2019
Benjamin Rosenstein
Head Formulator at Pharmocann Ltd. · since 2019
Internal Auditor · since 2019
Chairman of the Board · since 2019
Liran Yechiel Hen Halfon
Director · since 2019
Gil Hovesh
Chief Executive Officer, Director · since 2019
External Director · since 2015
IPO date
May 04, 2006
Employees
Domiciled in
IL
Incorporated in
IL

Valuation

No data to show